10 Characterised by high pressure and even higher stakes, clinical trials are environments in which business success is overshadowed only by the prospect of advancing the state of human health. These lifechanging studies must be kept moving forward, delivered through systems designed to drive confident decisions and calm action. Global technology firm Suvoda has stepped up to the plate in an increasingly complex industry, delivering a market-leading software platform equipped to support the most critical moments in a trial. We heard more from Robin Abadía below, Director of External Communications at Suvoda, as the company is named in the Global Excellence Awards 2026. For over a decade, Suvoda has been on a mission to advance human health by streamlining the clinical trial experience for patients, sites, sponsors, and CROs alike. To do so, it has developed a patented, realtime software platform that is purpose-built for the most complex, mission-critical, and time-sensitive moments in studies. This platform empowers sponsors and sites to make confident decisions and take calm action whilst operating within high-stakes studies. Suvoda was founded in 2013 by CEO Jagath Wanninayake, COO Robert Hummel, and other experts who were driven by a desire to ease the complexities faced by clinical trial participants and professionals. Jagath’s background in clinical trial technology, which also includes previous experience as the Co-Founder of Clarix LLC, has laid the foundation for Suvoda’s innovative approach to clinical trials and has since propelled the team to significant success. The pioneering Suvoda Platform provides a suite of eight products on a single, patented ecosystem: IRT, eCOA, eConsent, Greephire Patient Payments, Greenphire Travel, Scheduling, Site Payments, and Budgeting and Benchmarking. This fully integrated model minimises friction and maximises engagement for sponsors, CROs, sites, and patients, not only simplifying but enhancing the experience and contributions of all users across the clinical journey. “We support even the most time-sensitive, mission-critical points of a trial, so that life-changing studies keep moving forward and everyone involved can ‘trial wisely’.” “You’ll hear the term ‘platform’ used in many ways in our industry,” said Robin. “At Suvoda, it reflects a unified architecture built intentionally as a single system. Rather than integrating standalone products, our patented, modern back-end supports connected workflows and a streamlined user experience across the trial lifecycle.” Using the Suvoda Platform, study teams benefit from a single log-in, a unified data layer, and an intuitive interface that was created with user-centricity in mind. Beyond the technology itself, the company’s exceptionally prepared client services teams support sponsors and CROs for the full lifespan of each trial, providing protocol-level expertise, calm guidance, and global support. Since its launch, Suvoda has been chosen to support sponsors and CROs in more than 2,000 trials across over 95 countries, including many of the most complex and high-stakes studies in oncology and rare disease. Meticulously monitoring customer satisfaction and feedback, the company consistently achieves scores that exceed typical technology industry benchmarks, reflecting the trust that clients have placed in its platform and services. External validation, from industry awards and analyst reports to strategic partnerships and growing adoption, have further evidenced that Suvoda is meaningfully enhancing the clinical trial journey. “We pride ourselves on being deeply patient- and site-centric, designing digital experiences that not only streamline trial operations but also reduce friction for the people actually moving through trials,” Robin told us. “People now expect, and deserve, Suvoda: Pioneering For Patients, For Professionals, For Progress “Together, we Trial wisely.”
RkJQdWJsaXNoZXIy NTY1MjM3